US 9593163
Oncostatin M receptor antigen binding proteins
granted A61KA61K39/395A61P
Quick answer
US patent 9593163 (Oncostatin M receptor antigen binding proteins) held by Kiniksa Pharmaceuticals, GmbH expires Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Kiniksa Pharmaceuticals, GmbH
- Grant date
- Tue Mar 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K39/395, A61P, A61P1/16, A61P1/18